WWM
RXST icon

Wolff Wiese Magana’s RxSight RXST Stock Holding History

Wolff Wiese Magana’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-340
Closed -$4K – 943
2022
Q3 		$4K Hold
340
– – ﹤0.01% 653
2022
Q2 		$5K Hold
340
– – ﹤0.01% 640
2022
Q1 		$4K Hold
340
– – ﹤0.01% 669
2021
Q4 		$4K Hold
340
– – ﹤0.01% 671
2021
Q3 		$4K Buy
+340
New +$4.68K ﹤0.01% 654

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wolff Wiese Magana's RXST Position: Q4 2022 in Review

Wolff Wiese Magana sold out of RxSight (RXST) in Q4 2022, closing a stake of 340 shares — an estimated $4K sold.

Wolff Wiese Magana first reported a position in RXST in Q3 2021 and held it in 5 quarters. The position peaked at $5K in Q2 2022. 58 funds tracked by Wall St. Rank hold RXST as of Q4 2022.

  • Wolff Wiese Magana reported no remaining RxSight position as of Q4 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 340 RxSight shares in Q4 2022, an estimated $4K.
  • Wolff Wiese Magana first reported a position in RxSight in Q3 2021 and held it in 5 quarters.
  • Wolff Wiese Magana's RxSight position peaked at $5K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held RxSight as of Q4 2022.

Based on Wolff Wiese Magana's 13F filing for Q4 2022, filed 9 Feb 2023.